Report Content
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates & working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Digital therapeutics industry 3600 synopsis, 2018-2032
2.2 Business trends
2.2.1 Component trends
2.2.2 Application trends
2.2.3 Sales channel trends
2.2.4 Regional trends
Chapter 3 Digital Therapeutics Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018-2032 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing prevalence of chronic diseases
3.3.1.2 Rising need for cost containment
3.3.1.3 Potential to increase quality of care delivery
3.3.1.4 Growing popularity of digital therapeutics
3.3.2 Industry pitfalls & challenges
3.3.2.1 Security and privacy issues
3.3.2.2 Lack of skilled IT professionals
3.4 Growth potential analysis
3.4.1 By component
3.4.2 By application
3.4.3 By sales channel
3.5 COVID-19 impact analysis
3.6 Differences between digital health, digital medicine and digital therapeutics
3.7 Regulatory landscape
3.7.1 U.S.
3.7.2 Europe
3.8 Reimbursement scenario
3.8.1 U.S.
3.8.2 Europe
3.9 Investment overview
3.10 Technology trend analysis
3.11 R&D pipeline for leading digital therapeutics companies
3.12 Digital therapeutics use cases per therapeutic area and example applications
3.13 Impact of digital therapeutics on key stakeholders
3.14 Digital Therapeutics-Biopharma deals, 2019
3.15 Porter’s analysis
3.16 PESTEL analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Strategy dashboard, 2021
Chapter 5 Digital Therapeutics Market, By Component
5.1 Key segment trends
5.2 Software
5.2.1 Market size, by region, 2018-2032 (USD Million)
5.3 Device
5.3.1 Market size ,by region, 2018-2032 (USD Million)
Chapter 6 Digital Therapeutics Market, By Application
6.1 Key segment trends
6.2 Diabetes
6.2.1 Market size, by region, 2018-2032 (USD Million)
6.3 Obesity
6.3.1 Market size, by region, 2018-2032 (USD Million)
6.4 Cardiovascular
6.4.1 Market size, by region, 2018-2032 (USD Million)
6.5 Mental & behavioral health
6.5.1 Market size, by region, 2018-2032 (USD Million)
6.6 Hypertension
6.6.1 Market size, by region, 2018-2032 (USD Million)
6.7 Insomnia
6.7.1 Market size, by region, 2018-2032 (USD Million)
6.8 Others
6.8.1 Market size, by region, 2018-2032 (USD Million)
Chapter 7 Digital Therapeutics Market, By Sales channel
7.1 Key segment trends
7.2 Business-to-business (B2B)
7.2.1 Market size, by region, 2018-2032 (USD Million)
7.3 Business-to-consumers (B2C)
7.3.1 Market size, by region, 2018-2032 (USD Million)
Chapter 8 Digital Therapeutics Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 Market size, by country, 2018-2032 (USD Million)
8.2.2 Market size, by component, 2018-2032 (USD Million)
8.2.3 Market size, by application, 2018-2032 (USD Million)
8.2.4 Market size, by sales channel, 2018-2032 (USD Million)
8.2.5 U.S.
8.2.5.1 Market size, by component, 2018-2032 (USD Million)
8.2.5.2 Market size, by application, 2018-2032 (USD Million)
8.2.5.3 Market size, by sales channel, 2018-2032 (USD Million)
8.2.6 Canada
8.2.6.1 Market size, by component, 2018-2032 (USD Million)
8.2.6.2 Market size, by application, 2018-2032 (USD Million)
8.2.6.3 Market size, by sales channel, 2018-2032 (USD Million)
8.3 Europe
8.3.1 Market size, by country, 2018-2032 (USD Million)
8.3.2 Market size, by component, 2018-2032 (USD Million)
8.3.3 Market size, by application, 2018-2032 (USD Million)
8.3.4 Market size, by sales channel, 2018-2032 (USD Million)
8.3.5 Germany
8.3.5.1 Market size, by component, 2018-2032 (USD Million)
8.3.5.2 Market size, by application, 2018-2032 (USD Million)
8.3.5.3 Market size, by sales channel, 2018-2032 (USD Million)
8.3.6 UK
8.3.6.1 Market size, by component, 2018-2032 (USD Million)
8.3.6.2 Market size, by application, 2018-2032 (USD Million)
8.3.6.3 Market size, by sales channel, 2018-2032 (USD Million)
8.3.7 France
8.3.7.1 Market size, by component, 2018-2032 (USD Million)
8.3.7.2 Market size, by application, 2018-2032 (USD Million)
8.3.7.3 Market size, by sales channel, 2018-2032 (USD Million)
8.3.8 Italy
8.3.8.1 Market size, by component, 2018-2032 (USD Million)
8.3.8.2 Market size, by application, 2018-2032 (USD Million)
8.3.8.3 Market size, by sales channel, 2018-2032 (USD Million)
8.3.9 Spain
8.3.9.1 Market size, by component, 2018-2032 (USD Million)
8.3.9.2 Market size, by application, 2018-2032 (USD Million)
8.3.9.3 Market size, by sales channel, 2018-2032 (USD Million)
8.4 Asia Pacific
8.4.1 Market size, by country, 2018-2032 (USD Million)
8.4.2 Market size, by component, 2018-2032 (USD Million)
8.4.3 Market size, by application, 2018-2032 (USD Million)
8.4.4 Market size, by sales channel, 2018-2032 (USD Million)
8.4.5 Japan
8.4.5.1 Market size, by component, 2018-2032 (USD Million)
8.4.5.2 Market size, by application, 2018-2032 (USD Million)
8.4.5.3 Market size, by sales channel, 2018-2032 (USD Million)
8.4.6 China
8.4.6.1 Market size, by component, 2018-2032 (USD Million)
8.4.6.2 Market size, by application, 2018-2032 (USD Million)
8.4.6.3 Market size, by sales channel, 2018-2032 (USD Million)
8.4.7 India
8.4.7.1 Market size, by component, 2018-2032 (USD Million)
8.4.7.2 Market size, by application, 2018-2032 (USD Million)
8.4.7.3 Market size, by sales channel, 2018-2032 (USD Million)
8.4.8 Australia
8.4.8.1 Market size, by component, 2018-2032 (USD Million)
8.4.8.2 Market size, by application, 2018-2032 (USD Million)
8.4.8.3 Market size, by sales channel, 2018-2032 (USD Million)
8.4.9 Singapore
8.4.9.1 Market size, by component, 2018-2032 (USD Million)
8.4.9.2 Market size, by application, 2018-2032 (USD Million)
8.4.9.3 Market size, by sales channel, 2018-2032 (USD Million)
8.5 Latin America
8.5.1 Market size, by country, 2018-2032 (USD Million)
8.5.2 Market size, by component, 2018-2032 (USD Million)
8.5.3 Market size, by application, 2018-2032 (USD Million)
8.5.4 Market size, by sales channel, 2018-2032 (USD Million)
8.5.5 Mexico
8.5.5.1 Market size, by component, 2018-2032 (USD Million)
8.5.5.2 Market size, by application, 2018-2032 (USD Million)
8.5.5.3 Market size, by sales channel, 2018-2032 (USD Million)
8.5.6 Brazil
8.5.6.1 Market size, by component, 2018-2032 (USD Million)
8.5.6.2 Market size, by application, 2018-2032 (USD Million)
8.5.6.3 Market size, by sales channel, 2018-2032 (USD Million)
8.6 MEA
8.6.1 Market size, by country, 2018-2032 (USD Million)
8.6.2 Market size, by component, 2018-2032 (USD Million)
8.6.3 Market size, by application, 2018-2032 (USD Million)
8.6.4 Market size, by sales channel, 2018-2032 (USD Million)
8.6.5 Saudi Arabia
8.6.5.1 Market size, by component, 2018-2032 (USD Million)
8.6.5.2 Market size, by application, 2018-2032 (USD Million)
8.6.5.3 Market size, by sales channel, 2018-2032 (USD Million)
8.6.6 South Africa
8.6.6.1 Market size, by component, 2018-2032 (USD Million)
8.6.6.2 Market size, by application, 2018-2032 (USD Million)
8.6.6.3 Market size, by sales channel, 2018-2032 (USD Million)
8.6.7 Israel
8.6.7.1 Market size, by component, 2018-2032 (USD Million)
8.6.7.2 Market size, by application, 2018-2032 (USD Million)
8.6.7.3 Market size, by sales channel, 2018-2032 (USD Million)
Chapter 9 Company Profiles
9.1 Otsuka Holdings Co., Ltd.
9.1.1 Business overview
9.1.2 Financial data
9.1.3 Product landscape
9.1.4 Strategic outlook
9.1.5 SWOT analysis
9.2 Propeller Health (ResMed)
9.2.1 Business overview
9.2.2 Financial data
9.2.3 Product landscape
9.2.4 Strategic outlook
9.2.5 SWOT analysis
9.3 Virta Health Corp
9.3.1 Business overview
9.3.2 Financial data
9.3.3 Product landscape
9.3.4 Strategic outlook
9.3.5 SWOT analysis
9.4 Teladoc Health
9.4.1 Business overview
9.4.2 Financial data
9.4.3 Product landscape
9.4.4 Strategic outlook
9.4.5 SWOT analysis
9.5 Pear Therapeutics Inc
9.5.1 Business overview
9.5.2 Financial data
9.5.3 Product landscape
9.5.4 Strategic outlook
9.5.5 SWOT analysis
9.6 Omada Health Inc
9.6.1 Business overview
9.6.2 Financial data
9.6.3 Product landscape
9.6.4 Strategic outlook
9.6.5 SWOT analysis
9.7 Akili Interactive Labs
9.7.1 Business overview
9.7.2 Financial data
9.7.3 Product landscape
9.7.4 Strategic outlook
9.7.5 SWOT analysis
9.8 WellDoc, Inc.
9.8.1 Business overview
9.8.2 Financial data
9.8.3 Product landscape
9.8.4 Strategic outlook
9.8.5 SWOT analysis
9.9 Click Therapeutics
9.9.1 Business overview
9.9.2 Financial data
9.9.3 Product landscape
9.9.4 Strategic outlook
9.9.5 SWOT analysis
9.10 Biofourmis, Inc.
9.10.1 Business overview
9.10.2 Financial data
9.10.3 Product landscape
9.10.4 Strategic outlook
9.10.5 SWOT analysis
9.11 Lark Health
9.11.1 Business overview
9.11.2 Financial data
9.11.3 Product landscape
9.11.4 Strategic outlook
9.11.5 SWOT analysis
9.12 LifeScan, Inc.
9.12.1 Business overview
9.12.2 Financial data
9.12.3 Product landscape
9.12.4 Strategic outlook
9.12.5 SWOT analysis
9.13 DarioHealth
9.13.1 Business overview
9.13.2 Financial data
9.13.3 Product landscape
9.13.4 Strategic outlook
9.13.5 SWOT analysis
9.14 Voluntis
9.14.1 Business overview
9.14.2 Financial data
9.14.3 Product landscape
9.14.4 Strategic outlook
9.14.5 SWOT analysis
9.15 My Sugr (Roche)
9.15.1 Business overview
9.15.2 Financial data
9.15.3 Product landscape
9.15.4 Strategic outlook
9.15.5 SWOT analysis
